Constellation Pharmaceuticals Inc (CNST)

NASDAQ
20.80
-0.24(-1.14%)
After Hours
20.80
0.00(0.00%)
- Real-time Data
  • Volume:
    337,373
  • Bid/Ask:
    12.50/20.80
  • Day's Range:
    20.49 - 21.53

CNST Overview

Prev. Close
21.04
Day's Range
20.49 - 21.53
Revenue
-
Open
21.1
52 wk Range
17 - 50.9
EPS
-2.8
Volume
337,373
Market Cap
996.61M
Dividend (Yield)
N/A (N/A)
Average Vol. (3m)
446,642
P/E Ratio
-
Beta
-
1-Year Change
-57.74%
Shares Outstanding
47,914,035
Next Earnings Date
May 10, 2021
What is your sentiment on Constellation Pharmaceuticals Inc?
or
Market is currently closed. Voting is open during market hours.

Constellation Pharmaceuticals Inc News

Constellation Pharmaceuticals Inc Analysis

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesBuyNeutralSellStrong SellNeutral
Technical IndicatorsStrong BuyStrong BuyStrong SellStrong SellStrong Sell
SummaryStrong BuyBuyStrong SellStrong SellSell

Constellation Pharmaceuticals Inc Company Profile

Constellation Pharmaceuticals Inc Company Profile

Employees
154

Constellation Pharmaceuticals, Inc. discovers and develops small molecule therapeutics for the treatment of cancer, inflammatory/immunologic disorders and other diseases. The Company has three clinical-stage oncology development programs: the first program is evaluating a compound, CPI-0610, other program is evaluating a compound, CPI-1205 and CPI-0209 is initiate Phase I clinical trial and targeting solid tumors. CPI-1205 is a small molecule designed to promote anti-tumor activity by specifically inhibiting EZH2, an enzyme that suppresses target gene expression. CPI-0610 is a potent and selective small molecule designed to promote anti-tumor activity by selectively inhibiting the function of BET proteins, which are proteins that normally enhance target gene expression. The Company is conducting the ProSTAR trial, which is an open-label Phase Ib/2 clinical trial of CPI-1205 for the treatment of mCRPC in combination with enzalutamide and abiraterone acetate.

Read More
  • classic pump and dump
    5
    • holding up well for a pump and dump
      1
  • any news?
    0
    • 15 >>> 45
      0
  • looks like you're right alix
    0
    • looks like you're right alix
      0
      • stock is going soar this month, fda approval
        0
        • stock is going soar this month, fda approval
          0
          Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
          Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.